07/11/2016 Leeds, 11 July 2016 – Tissue Regenix Group (AIM:TRX) (‘Tissue Regenix’ or ‘The Group’) the regenerative medical devices company today updates on its strategy for OrthoPure™ XT and XM (porcine tendon and meniscus) market clearance pathways. The Group is currently undertaking clinical trials within the EU for both products, and due to the success […]